These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31959422)

  • 1. Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.
    Stinson JA; Palmer CR; Miller DP; Li AB; Lightner K; Jost H; Weldon WC; Oberste MS; Kluge JA; Kosuda KM
    Vaccine; 2020 Feb; 38(7):1652-1660. PubMed ID: 31959422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
    Anand A; Molodecky NA; Pallansch MA; Sutter RW
    Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative delivery of a thermostable inactivated polio vaccine.
    Kraan H; Ploemen I; van de Wijdeven G; Que I; Löwik C; Kersten G; Amorij JP
    Vaccine; 2015 Apr; 33(17):2030-7. PubMed ID: 25772676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
    Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
    mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
    Murakami K; Fujii Y; Someya Y
    Vaccine; 2020 Apr; 38(17):3295-3299. PubMed ID: 32197923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national reference for inactivated polio vaccine derived from Sabin strains in Japan.
    Shirato H; Someya Y; Ochiai M; Horiuchi Y; Takahashi M; Takeda N; Wakabayashi K; Ouchi Y; Ota Y; Tano Y; Abe S; Yamazaki S; Wakita T;
    Vaccine; 2014 Sep; 32(40):5163-9. PubMed ID: 25090648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
    Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
    J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.
    White JA; Estrada M; Weldon WC; Chumakov K; Kouiavskaia D; Fournier-Caruana J; Stevens E; Gary HE; Maes EF; Oberste MS; Snider CJ; Anand A; Chen D
    Biologicals; 2018 May; 53():30-38. PubMed ID: 29548791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba.
    Resik S; Tejeda A; Fonseca M; Alemañi N; Diaz M; Martinez Y; Garcia G; Okayasu H; Burton A; Bakker WA; Verdijk P; Sutter RW
    Vaccine; 2014 Sep; 32(42):5399-404. PubMed ID: 25131734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
    Xiao Y; Daniell H
    Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Kraan H; Ten Have R; van der Maas L; Kersten G; Amorij JP
    Vaccine; 2016 Aug; 34(38):4572-4578. PubMed ID: 27470209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.
    Bockstal V; Tiemessen MM; Achterberg R; Van Wordragen C; Knaapen AM; Serroyen J; Marissen WE; Schuitemaker H; Zahn R
    Vaccine; 2018 Nov; 36(46):6979-6987. PubMed ID: 30314910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model.
    Norton EB; Bauer DL; Weldon WC; Oberste MS; Lawson LB; Clements JD
    Vaccine; 2015 Apr; 33(16):1909-15. PubMed ID: 25765967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants.
    Gao S; Wei M; Chu K; Li J; Zhu F
    Hum Vaccin Immunother; 2022 Nov; 18(5):2050106. PubMed ID: 35394898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.
    Tzeng SY; Guarecuco R; McHugh KJ; Rose S; Rosenberg EM; Zeng Y; Langer R; Jaklenec A
    J Control Release; 2016 Jul; 233():101-13. PubMed ID: 27178811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array.
    Wan Y; Hickey JM; Bird C; Witham K; Fahey P; Forster A; Joshi SB; Volkin DB
    J Pharm Sci; 2018 Jun; 107(6):1540-1551. PubMed ID: 29421219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.
    Rivera L; Pedersen RS; Peña L; Olsen KJ; Andreasen LV; Kromann I; Nielsen PI; Sørensen C; Dietrich J; Bandyopadhyay AS; Thierry-Carstensen B
    Lancet Infect Dis; 2017 Jul; 17(7):745-753. PubMed ID: 28454674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.